• Skip to content
  • Accessibility help
Skip to content
Sign in
  • Guidance
  • Standards and indicators
  • Clinical Knowledge Summaries (CKS)
  • British National Formulary (BNF)
  • British National Formulary for Children (BNFC)
  • Life sciences
  • Skip More from NICE submenu

    Explore more from NICE

    • What NICE does
    • About us
    • Reusing our content
    • Implementing NICE guidance
    • News, blogs and podcasts
    • Contact us
    • Get involved
    • Careers

    • Join a committee
    • Comment on a consultation

My account

  • Consultation responses
  • Sign in

You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Head and neck cancers

Leukocyte interleukin in combination for neoadjuvant treatment of resectable locally advanced squamous cell head and neck cancer [ID6390]

  • In development
  • Reference number: GID-TA11475
  • Expected publication date: TBC
  • Project information
  • Project documents

NIHRIO BN: 5578-Multikine-with-Cyclophosphamide-Indomethacin-and-Zinc-for-Head-and-Neck-Cancer-V1.0-OCT2023-NON-CONF.pdf (nihr.ac.uk)

Back to top
  • Guidance
  • Standards and indicators
  • Clinical Knowledge Summaries (CKS) Clinical Knowledge SummariesClinical Knowledge Summaries
  • British National Formulary (BNF) British National FormularyBritish National Formulary
  • British National Formulary for Children (BNFC) British National Formulary for ChildrenBritish National Formulary for Children
  • Life sciences
  • Library and knowledge services
  • What NICE does
  • Implementing NICE guidance
  • Get involved
  • About us
  • Careers
  • News, blogs and podcasts
  • Newsletters and alerts
  • Contact us
  • Leave feedback
  • Reusing our content
  • NICE UK Open Content Licence
  • Syndicate our content
  • Events
  • Facebook
  • X
  • YouTube
  • LinkedIn
  • Accessibility
  • Freedom of information
  • Glossary
  • Terms and conditions
  • Privacy notice
  • Cookies

© NICE 2025. All rights reserved. Subject to Notice of rights.